$BTX a long term buy and hold – $ASTY

Sludge Reports has been in BTX since mid-2013.  While suffering some red in the portfolio, shares were added to the position confidently.  This long term hold is truly worth holding a long time!  There is value to be unlocked for years.

While a Research Report was in the works,  yesterday’s Renshaw presentation was truly comprehensive on both the science and investment fronts.   BTX is moving from a research phase company into revenue generating phases on some fronts.

BTX’s Renshaw presentation replay

Also of note are the insider transactions. Pay particular attention to Neal Bradsher’s (Broadwood) transactions.Neal is a director at Questcor and Biotime (see below).  Over the preceding year, Neal moved profits from Questcor into Biotime, adding on some nice dips.   Neal is a long term investor in all positions.  He isn’t a trader, but rather a long, long term value investor.

BTX is 40% owned by long term investors.  Shorts shouldn’t get their hopes up that Neal will sell any shares until we are well into the 2020s.

Issuer Filings Transaction Date Type of Owner
QUESTCOR PHARMACEUTICALS INC 0000891288 2014-08-14 director
COMARCO INC 0000022252 2014-08-13 10 percent owner
BIOTIME INC 0000876343 2014-07-22 director, 10 percent owner
Asterias Biotherapeutics, Inc. 0001572552 2014-06-16 other: See remarks section.
STAAR SURGICAL CO 0000718937 2013-12-12 10 percent owner
0000881695 2013-06-24 10 percent owner

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s